INVESTOR ALERT: Investigation of USANA Health Sciences Inc. Announced by Glancy Binkow & Goldberg LLP
24 7월 2014 - 4:32AM
Business Wire
Glancy Binkow & Goldberg LLP announces that it is
investigating potential claims on behalf of investors of USANA
Health Sciences Inc. (“USANA” or the “Company”) (NYSE:USNA)
concerning possible violations of federal securities laws. The
investigation focuses on certain statements issued by the Company
concerning USANA’s business and operations.
Please contact us at (310) 201-9150, or at
shareholders@glancylaw.com to discuss this matter. If you inquire
by email please include your mailing address, telephone number and
number of shares purchased.
USANA develops, manufactures and sells nutritional and personal
care products focusing on chronic degenerative disease worldwide.
The investigation is related to allegations that the Company may
have made false and misleading disclosures concerning its
operations, true financial condition, and financial prospects, and
that the Company has engaged in widespread, illegal multi-level
marketing operations in China.
If you purchased USANA shares, if you have information or would
like to learn more about these claims, or if you have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Michael Goldberg, Esquire,
of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite
2100, Los Angeles, California 90067, Toll Free at (888) 773-9224,
by e-mail to shareholders@glancylaw.com, or visit our website at
http://www.glancylaw.com. If you inquire by email please include
your mailing address, telephone number and number of shares
purchased.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
Glancy Binkow & Goldberg LLP, Los Angeles, CAMichael
Goldberg, 888-773-9224shareholders@glancylaw.comwww.glancylaw.com
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024